Targepeutics Employee Directory
Biotechnology ResearchPennsylvania, United States2-10 Employees
Targepeutics is a biotechnology research company focused on developing selective molecularly targeted therapeutics to treat cancer and other diseases. Its lead candidate, GB-13, is advancing toward a Phase I trial for multiple cancer targets and is a recombinant protein designed to bind and destroy cancer cells with minimal impact on normal cells. The company is based in Hershey, Pennsylvania, and operates as a small team. In addition to GB-13, Targepeutics has licensed related technology for a cancer immunotherapy that is in Phase III trials. The company has engaged with the oncology research community, including presenting data at the 29th Annual Meeting of the Society of Neuro-Oncology in 2024.